Abstract 283P
Background
Bone fracture is a devastating event in patients with mCRC. Nevertheless, no study has compared OF and PF in these patients.
Methods
We retrospectively analyzed clinical data of patients with mCRC who underwent palliative first-line oxaliplatin or irinotecan backbone chemotherapy at Seoul National University Bundang Hospital. This study aimed to identify the cumulative incidence rates of OF and PF in these patients and their risk factors.
Results
A total of 622 patients (male, 359) were consecutively enrolled between Jan. 2008 and Dec. 2015. The median age was 61 years (range, 20-91 years). Before palliative first-line chemotherapy (oxaliplatin backbone and irinotecan backbone in 313 [50.3%] and 309 [49.7%] patients, respectively), the median body mass index was 22.6 kg/m2 (range, 13.8-36.2 kg/m2) and bone metastasis was found in 42 patients (6.8%). During a median follow-up of 65.5 months (range 1.6-126.0 months), the median overall survival was 27.2 months (95% confidence interval [CI], 24.5-29.9 months). Among 81 patients (13.0%) who experienced OF or PF events, OF, PF, and both developed in 42 (6.8%), 36 (5.8%), and 3 (0.5%) patients, respectively. The cumulative incidence rates of OF and PF were 3.4% (95% CI, 2.2-5.0%) and 2.7% (95% CI, 1.7-4.3%) at 1 year, 4.5% (95% CI, 3.1-6.4%) and 4.2% (95% CI, 2.8-6.0%) at 2 years, and 5.6% (95% CI, 3.9-7.6%) and 5.1% (95% CI, 3.5-7.0%) at 3 years, respectively. The cumulative incidence rate of the first OF or PF was 6.0% (95% CI, 4.3-8.0%) at 1 year, 8.6% (95% CI, 6.6-11.0) at 2 years, and 10.4% (95% CI, 8.2-13.0%) at 3 years. The most common fracture sites were the lumbar spines (52.4%) in OF and the thoracic spines (50.0%) in PF, respectively. The OF risk was significantly higher in patients with age ≥ 65 years (hazard ratio [HR] 3.20 [95% CI, 1.73-5.92], p<0.001) while the PF risk was not significant between the age groups (HR 0.77 [95% CI, 0.40-1.49], p=0.430).
Conclusions
Fracture events were substantial in patients with mCRC who received palliative chemotherapy. Notably, the incidence of OF was comparable with that of PF. Therefore, OF should be considered in elderly patients with lumbar spine fractures.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
281P - Cancer-related symptoms as mediators between treatment and functional capacity in adolescents and young adults (AYAs) with cancer
Presenter: Chung Tin Justin Ma
Session: Poster viewing 04
282P - Nutritional status and nutritional therapy of common cancer in a cancer hospital of Southwest China
Presenter: Huiqing Yu
Session: Poster viewing 04
284P - Gut microbiota mediates the protective effects of resveratrol against the intestinal barrier dysfunction in non-alcoholic steatohepatitis induced by high-fat diet
Presenter: Haoyang Cao
Session: Poster viewing 04
285P - Reticulocyte hemoglobin equivalent as an early predictor of iron deficiency anemia in cancer patients
Presenter: Aditya Sarin
Session: Poster viewing 04
286P - Breakthrough COVID-19 infections in patients with cancer from a prospective study of COVID-19 vaccine response
Presenter: Amy Body
Session: Poster viewing 04
287P - Long-term yoga enhances the quality of life and symptomatic scale in breast cancer patients undergoing treatment
Presenter: Mayank Jain
Session: Poster viewing 04
288P - Impact of hormonal contraception on estradiol and progesterone serum levels: A 6-year study on progression-free survival, disease-free survival, and overall survival at Dr. Moewardi Hospital
Presenter: Widyanti Soewoto
Session: Poster viewing 04
289P - Cancer cachexia following breast cancer (BC) chemotherapy was associated with clinical stage, number of chemotherapy cycles, and vitamin D concentration
Presenter: Susanna Hutajulu
Session: Poster viewing 04
290P - Use of PEG G-CSF is associated with decreased myelotoxicity in dexrazoxane-used aggressive non-Hodgkin lymphoma patients
Presenter: Sung-Nam Lim
Session: Poster viewing 04
291P - Assessment of nutritional status in cancer patients using patient generated subjective global assessment screening tool
Presenter: Anuj K. C.
Session: Poster viewing 04